Amy Pomeroy
@amypomeroy.bsky.social
📤 23
📥 21
📝 13
computational cancer pharmacologist at UNC | modeling clinical trials of combination therapy
reposted by
Amy Pomeroy
9 months ago
New paper, with Amy Pomeroy! A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma now out in Blood Cancer Discovery:
doi.org/10.1158/2643...
#mathonc
#lymsm
#BloodCancer
1/n
loading . . .
A model of intra-tumor and inter-patient heterogeneity explains clinical trials of curative combination therapy for lymphoma
Abstract. Models of tumor drug response have illuminated important concepts in oncology, but there remains a need for theory that combines intra-tumor and inter-patient heterogeneity to explain patien...
https://doi.org/10.1158/2643-3230.BCD-24-0230
1
3
2
I am so excited to share that our new paper is out! A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma Out in Blood Cancer Discovery
doi.org/10.1158/2643-3230.BCD-24-0230
#mathonc
#lymsm
#BloodCancer
1/n
loading . . .
A model of intra-tumor and inter-patient heterogeneity explains clinical trials of curative combination therapy for lymphoma
Abstract. Models of tumor drug response have illuminated important concepts in oncology, but there remains a need for theory that combines intra-tumor and inter-patient heterogeneity to explain patien...
https://doi.org/10.1158/2643-3230.BCD-24-0230
9 months ago
1
7
4
reposted by
Amy Pomeroy
Association for Cancer Systems Biologists
11 months ago
An impressive result from their work - their model would have been able to predict from single treatment trials what would have happened in the combination trials
0
1
1
reposted by
Amy Pomeroy
Association for Cancer Systems Biologists
11 months ago
Dr. Amy Pomeroy is up next in our postdoc spotlight session telling us about their work on mechanistic modeling of combination therapy
doi.org/10.1101/2024...
1
3
2
you reached the end!!
feeds!
log in
